1 |
Xu J, Wu X, Chen J, Cheng Y, Zhang X. A TP53-associated metabolic gene signature for the prediction of overall survival and therapeutic responses in hepatocellular carcinoma. Journal of Radiation Research and Applied Sciences 2023;16:100552. [DOI: 10.1016/j.jrras.2023.100552] [Reference Citation Analysis]
|
2 |
Du W, Du S, Dong X, Bai H, Jiang J, Hao S, Yang F, Xiao Q, Zhang B, Ge J, Gao L, Li L, Yao SQ, Huang W. Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy. Biomaterials 2023;294:122000. [PMID: 36640541 DOI: 10.1016/j.biomaterials.2023.122000] [Reference Citation Analysis]
|
3 |
Zheng Y, Wang G, Li R, Geng H, Lei X, Chen L, Wu S, Yao J, Deng L. Promotion of intestinal epithelial cell apoptosis by enterotoxigenic Escherichia coli via PKA-mediated inhibition of mTORC1 activation. Microbes Infect 2023;:105099. [PMID: 36642296 DOI: 10.1016/j.micinf.2023.105099] [Reference Citation Analysis]
|
4 |
Qi Y, Xiao M, Xie P, Xie J, Guo M, Li F, Piao X. Comprehensive serum metabolomics and network analysis to reveal the mechanism of gypenosides in treating lung cancer and enhancing the pharmacological effects of cisplatin. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1070948] [Reference Citation Analysis]
|
5 |
Jiang P, Xue W, Xi C, Zhuang L, Yuan Z, Liu Z, Sun T, Xu X, Tan Y, Ding W. A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1016721] [Reference Citation Analysis]
|